Libertyville, IL, United States of America

John T Randolph

USPTO Granted Patents = 39 (Patent Applications = 25)

CIPO Patents = 7 (Patent Applications = 15)

EPO Patents = 20 (Patent Applications = 36)

Average Co-Inventor Count = 11.2

ph-index = 7

Forward Citations = 151(Granted Patents)

Location History:

Mundelein, IL (US) (1999 - 2000)
Libertyville, IL (US) (2008 - 2021)

Company Filing History:

Abbott Laboratories Corporation

patents

1 out of 5

Calico Life Sciences LLC

patents

where one patent can have more than one assignee

Years Active: 1999-2021

Loading Chart...

39 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11149043 - Prodrug modulators of the integrated stress pathway (2021-10-19),

2. 10668167 - Glucocorticoid receptor agonist and immunoconjugates thereof (2020-06-02),

3. 10053474 - Anti-viral compounds (2018-08-21),

4. 10039754 - Anti-viral compounds (2018-08-07),

5. 10028937 - Anti-viral compounds (2018-07-24),

6. 9676797 - Anti-viral compounds (2017-06-13),

7. 9637478 - Antiviral compounds and uses thereof (2017-05-02),

8. 9586978 - Anti-viral compounds (2017-03-07),

9. 9382258 - Agents for treating pain and uses thereof (2016-07-05),

10. 9353091 - Antiviral compounds and uses thereof (2016-05-31),

11. 9278922 - Anti-viral compounds (2016-03-08),

12. 9249138 - Anti-viral compounds (2016-02-02),

13. 9139536 - Anti-infective agents and uses thereof (2015-09-22),

14. 9029361 - Agents for treating pain and uses thereof (2015-05-12),

15. 9006387 - Anti-viral compounds (2015-04-14),

Title: Unveiling the Inventive Endeavors of John T. Randolph from Libertyville, IL

Introduction:

John T. Randolph, a prolific inventor hailing from Libertyville, IL, has made significant contributions to the field of pharmaceuticals with his groundbreaking patents and innovative approaches.

Latest Patents:

1. Prodrug modulators of the integrated stress pathway: These compounds, compositions, and methods demonstrate efficacy in modulating the integrated stress response (ISR) to address various diseases and conditions.

2. Glucocorticoid receptor agonist and immunoconjugates: Randolph's invention of glucocorticoid receptor agonist immunoconjugates opens new avenues in the treatment of autoimmune and inflammatory diseases.

Career Highlights:

With an impressive portfolio of 39 patents, Randolph has established himself as a leading figure in the pharmaceutical industry. His work showcases a deep understanding of biochemistry and drug development.

Collaborations:

During his career, John T. Randolph has collaborated with esteemed professionals such as Allan C. Krueger and David A. DeGoey. Together, they have pushed the boundaries of pharmaceutical innovation and research.

Conclusion:

In conclusion, John T. Randolph's innovative spirit and commitment to advancing medical science have left an indelible mark on the field of pharmaceuticals. His patents and collaborations stand as a testament to his passion for creating novel solutions to complex health challenges.

This text is generated by artificial intelligence and may not be accurate.